ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2026
eGFR- and Potassium-Guided Stewardship of SGLT2 Inhibitors and Finerenone in Albuminuric Chronic Kidney Disease Associated with Type 2 Diabetes.
Chen Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.